Military Veterans and Chronic Respiratory Diseases
Did you know that previously deployed U.S. military personnel have a higher risk of developing chronic respiratory lung diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and constrictive bronchiolitis?1
Diagnosing a lung disease in its early stages is the most important step for veterans so that medical professionals can be proactive in recognizing post deployment respiratory symptoms, determining the appropriate treatments and providing management options of symptoms.
Veterans who have been deployed and complained of respiratory symptoms such as persistent cough, shortness of breath and repeated respiratory infections should receive an evaluation and be screened as soon as possible.
of veterans deployed to Iraq and Afghanistan were more likely to have been diagnosed with sinusitis2
of military personnel who deployed reported chronic respiratory problems2
of more than 700K+ veterans met the criteria for one or more chronic pulmonary conditions such as asthma bronchitis or emphysema2
Breath Easy. Freedom is in the air.
AffloVest® is the first truly portable, battery-operated HFCWO airway clearance therapy vest, specifically engineered to give you the freedom and mobility to streamline therapy, enhance airway clearance, help mobilize lung secretions, and promote treatment adherence.
Designed to deliver seamless mobility, without the restriction of bulky hoses and generators, AffloVest allows patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases receive state-of-the-art airway clearance therapy on-the-go.
provides anatomically targeted therapy to improve bronchial drainage
has 3 modes of oscillation treatment designed to mimic hand CPT and 3 intensity levels for greater options and consistency
encourages treatment adherence and compliance through optimal design
Sponsored by AffloVest
In order to enhance treatment adherence and patient outcomes, AffloVest is always developing new ways to optimize important design features such as weight, noise, ergonomics, comfort, and ease-of-use.
All to provide the most efficient and effective balance between activity compatible design and therapy-optimizing functionality.
Lung function improvement in CF patients demonstrated in clinician papers.3
Patient feedback and testimonials show the AffloVest can provide more comfort and convenience than raditional air-bladder HFCWO vests.
Noise study demonstrates that AffloVest is the quietest HFCWO vest. Peak Magnetic Field test shows Afflovest is 4x lower than the threshold limit value for active medical device wearers and implanted medical devices.4
Contact us today!
If you would like more information about our home medical equipment and supplies, including the AffloVest, simply fill-out the form below or contact us (toll free) at (888) 450-6676 or email firstname.lastname@example.org.
1 Coleen B. Weese & Joseph H. Abraham, “Potential health implications associated with particulate matter exposure in deployed settings in southwest Asia.” Inhalation Toxicology Journal (2009); Vol. 21: 291-296.
2 Mary Jo Pugh, et al “Increasing Prevalence of Chronic Lung Disease in Veterans of the Wars in Iraq and Afghanistan” Military Medicine (2016); Vol. 181, Issue 5: 476-481.
3 Tackett, MW, et al. Lung function improvement with AffloVest® HFCWO use: a clinician’s perspective on PFT score data from 25 patients with cystic fibrosis. Cooper, M. An evidence-based study of adolescents with cystic fibrosis demonstrated that AffloVest® by International Biophysics contributed to improved lung function scores. Cooper, M. Clinician’s Data Analysis: Lung function improvement maintained over 16 to 24 months with use of AffloVest™ HFCWO vest by International Biophysics.
4 The comparison measurements were conducted at F2 Labs, an independent, 3rd party, ISO/IEC 17025 accredited testing laboratory. 16740 Peters Road, Middlefield, Ohio 44062. www.f2labs.com.